In Reply

Oncologist. 2021 Jul;26(7):e1286-e1287. doi: 10.1002/onco.13782. Epub 2021 Apr 19.

¹ Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
² Universitätsklinikum Ulm, Ulm, Germany.
³ Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain.
⁴ National Hospital Organization, Osaka National Hospital, Osaka, Japan.
⁵ Yonsei Cancer Center, Seoul, Republic of Korea.
⁶ Eli Lilly & Co, Paris, France.
⁷ Eli Lilly & Co, Madrid, Spain.
⁸ Eli Lilly & Co, Surrey, United Kingdom.
⁹ Mayo Clinic, Rochester, Minnesota, USA.

Abstract

This letter to the editor responds to Badoui et al. regarding data on abemaciclib dosages and adverse events.